ADMA Biologics Inc (NASDAQ:ADMA)

9.60
Delayed Data
As of 3:54pm ET
 +0.23 / +2.45%
Today’s Change
6.76
Today|||52-Week Range
14.00
-14.06%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for ADMA Biologics Inc have a median target of 19.00, with a high estimate of 20.00 and a low estimate of 17.50. The median estimate represents a +97.92% increase from the last price of 9.60.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in ADMA Biologics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.41
Sales
$1.4M
Reporting Date
Mar 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -12.50%
 
 
 
 
 
 
Growthannually 18.27%
 
 
 

Sales

Growthquarterly 1.10%
 
 
 
 
 
 
Growthannually 89.12%
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account